Adcock Ingram Holdings Limited (JSE:AIP)

Market Cap	10.98B +7.2%
Revenue (ttm)	9.76B +1.2%
Net Income	858.51M +5.5%
EPS	5.71 +8.5%
Shares Out	146.76M
PE Ratio	13.10
Forward PE	12.51
Dividend	2.80 (3.74%)
Ex-Dividend Date	Sep 17, 2025

Volume	719,869
Open	7,470.00
Previous Close	7,470.00
Day's Range	7,470.00 - 7,489.00
52-Week Range	4,301.00 - 7,489.00
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2025

About Adcock Ingram Holdings

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1890
• Employees: 2,610
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: AIP

Financial Performance

In 2025, Adcock Ingram Holdings's revenue was 9.76 billion, an increase of 1.22% compared to the previous year's 9.64 billion. Earnings were 858.51 million, an increase of 5.47%.